🇺🇸 FDA
Patent

US 10358447

Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same

granted A61KA61K31/4375A61K45/06

Quick answer

US patent 10358447 (Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4375, A61K45/06, A61P, A61P31/20